| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 45.241 | 55.888 | 68.052 | 59.294 | 59.771 | 48.176 | 63.805 | 68.053 | 71.350 |
| Total Income - EUR | - | 45.241 | 55.888 | 68.052 | 59.294 | 59.771 | 48.526 | 63.810 | 68.079 | 71.350 |
| Total Expenses - EUR | - | 4.724 | 15.013 | 18.701 | 21.766 | 22.603 | 27.147 | 37.864 | 38.747 | 40.940 |
| Gross Profit/Loss - EUR | - | 40.517 | 40.875 | 49.350 | 37.528 | 37.169 | 21.379 | 25.946 | 29.332 | 30.410 |
| Net Profit/Loss - EUR | - | 39.167 | 40.048 | 48.664 | 36.935 | 36.737 | 20.894 | 25.308 | 28.652 | 28.269 |
| Employees | - | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Alergoclinic Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 158 | 1.251 | 935 | 1.698 | 706 | 25.850 | 21.874 | 15.383 | 10.922 |
| Current Assets | - | 40.204 | 94.880 | 117.310 | 122.908 | 77.874 | 16.156 | 4.706 | 23.653 | 4.072 |
| Inventories | - | 0 | 1.140 | 1.298 | 1.456 | 0 | 235 | 0 | 0 | 8 |
| Receivables | - | 0 | 2.437 | 322 | 1.142 | 1.573 | 1.445 | 759 | 918 | 353 |
| Cash | - | 40.204 | 91.303 | 115.690 | 120.310 | 76.301 | 14.476 | 3.947 | 22.735 | 3.710 |
| Shareholders Funds | - | 39.211 | 64.771 | 89.617 | 93.762 | 77.581 | 40.910 | 25.357 | 38.146 | 13.758 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 1.151 | 31.360 | 28.627 | 30.845 | 999 | 1.446 | 1.360 | 1.647 | 1.997 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Alergoclinic Srl